Rotavirus vaccine - Nanotherapeutics
Latest Information Update: 25 Jan 2017
At a glance
- Originator Nanotherapeutics
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Rotavirus infections
Most Recent Events
- 25 Jan 2017 Preclinical trials in Rotavirus infections (Prevention) in USA before January 2017 (Nanotherapeutics pipeline, January 2017)